Germline Genetic Testing for Gene Variants Associate with Breast Cancer in Individuals at High B (Retired 8/1/2024)

Capital Blue Cross · PayerPolicy · CAPBLUE-MP-2.279-4340e3de

Source checked May 12, 2026 · Open the payer’s source

Status: Retired

Summary of the payer’s published policy. Not a coverage determination — confirm with Capital Blue Cross before submitting.

This version is retired

Capital Blue Cross has replaced or withdrawn this version, and Backwork could not match it to a current one. The payer’s current policies are listed on its page.

Capital Blue Cross policies Payer’s source